| Patents for A61P 1 - Drugs for disorders of the alimentary tract or the digestive system (125,798) |
|---|
| 03/31/2009 | CA2066204C Cystic fibrosis gene |
| 03/26/2009 | WO2009038842A2 Methods and compositions to inhibit edema factor and adenylyl cyclase |
| 03/26/2009 | WO2009038759A2 1-(4-(benzylbenzamid0) -benzyl) azetidine-3-carboxylic acid derivatives and related compounds as slp receptor modulators for the treatment of immune disorders |
| 03/26/2009 | WO2009038340A1 Pharmaceutical composition of artemisia extract using gastro-retentive drug delivery system and its oral sustained release formulation |
| 03/26/2009 | WO2009038266A1 Method for enhancing serum stability and lowering immune response of sirna down-regulating gene expression of hbv or hcv |
| 03/26/2009 | WO2009038204A1 Novel long-chain fatty acid derivative compound and g-protein-coupled receptor agonist containing the compound as active ingredient |
| 03/26/2009 | WO2009038057A1 Nitrogenated fused-ring derivative, pharmaceutical composition comprising the same, and use of the same for medical purposes |
| 03/26/2009 | WO2009038021A1 4-sulfonylpiperidine derivatives |
| 03/26/2009 | WO2009037855A1 Oral and skin compositions |
| 03/26/2009 | WO2009037264A2 Colonic delivery of antimicrobial agents |
| 03/26/2009 | WO2009036590A1 Compounds isolated from antrodia cinnamomea and use thereof |
| 03/26/2009 | WO2009017624A3 Compositions with enhanced bioavailability and fast acting inhibitor of gastric acid secretion |
| 03/26/2009 | WO2008153884A8 Compositions useful for treating gastroesophageal reflux disease |
| 03/26/2009 | WO2008137780A3 Use of [3.2.0] heterocyclic compounds and analogs thereof for treating infectious diseases |
| 03/26/2009 | WO2008058897A3 Diphyllin and other lignans as a medicament for v-atpase mediated disease |
| 03/26/2009 | WO2005044802A3 Tetrahydro-quinolinylurea derivatives as vrl antagonists |
| 03/26/2009 | US20090082567 2,4-pyrimidinediamine compounds and their uses |
| 03/26/2009 | US20090082444 Compositions for the Treatment of Blood Disorders |
| 03/26/2009 | US20090082442 Deuterium-enriched lubiprostone |
| 03/26/2009 | US20090082419 Deuterium-enriched tegaserod |
| 03/26/2009 | US20090082369 Pyrrolo[2,3d]pyrimidine compositions and their use |
| 03/26/2009 | US20090082368 Methods of modulating neurotrophin-mediated activity |
| 03/26/2009 | US20090082356 Pyrazine Derivatives and Use as P13k Inhibitors |
| 03/26/2009 | US20090082343 1,3-benzothiazinone derivatives and use thereof |
| 03/26/2009 | US20090082331 S1p receptor modulating compounds and use thereof |
| 03/26/2009 | US20090082306 Deuterium-enriched telbivudine |
| 03/26/2009 | US20090082292 inhibiting angiogenesis; corneal graft rejection; age related macular degeneration; diabetic retinopathy; dermatological disease |
| 03/26/2009 | US20090082279 Treating a condition associated with breakdown of the blood brain barrier by administering a peptide antagonist of zonulin that binds to the zonula occludens receptor, especially in the brain, yet does not physiologically modulate the opening of mammalian tight junctions |
| 03/26/2009 | US20090082260 Combination of an immunosuppressant and a ppar gamma agonist for the treatment of an undesirable immune response |
| 03/26/2009 | US20090081732 Antibodies to human il-1beta |
| 03/26/2009 | US20090081729 Compositions and Methods Comprising a Ligand of ChemerinR |
| 03/26/2009 | US20090081294 Sustained release dosage form for lubricating an oral cavity |
| 03/26/2009 | US20090081283 Tumor therapy with non-viral-based high affinitiy laminin receptor-targeted vectors |
| 03/26/2009 | US20090081242 Methods of therapy for b-cell malignancies using antagonist anti-cd40 antibodies |
| 03/26/2009 | US20090081229 Anti-pro87299 antibodies |
| 03/26/2009 | US20090081167 Folic acid producing bifidobaterium bacterial strains, formulations and use thereof |
| 03/26/2009 | US20090081131 Tumor therapy with high affinity laminin receptor-targeted vectors and compounds |
| 03/26/2009 | US20090081126 Novel fully human anti-VAP-1 monoclonal antibodies |
| 03/26/2009 | US20090081123 Pharmaceutical compounds |
| 03/26/2009 | CA2699417A1 S1p receptor modulating compounds and use thereof |
| 03/26/2009 | CA2699275A1 4-sulfonylpiperidine derivative |
| 03/26/2009 | CA2692004A1 Methods and compositions to inhibit edema factor and adenylyl cyclase |
| 03/25/2009 | EP2039779A1 Screening method |
| 03/25/2009 | EP2039700A2 Novel anti-inflammatory androstane derivatives |
| 03/25/2009 | EP2039686A1 Dihydropyrimidine compounds and their uses in preparation of medicaments for treating and preventing antiviral diseases |
| 03/25/2009 | EP2039681A1 Cycloalkene derivatives, process for production of the derivatives, and use of the same |
| 03/25/2009 | EP2039362A1 Tooth enamel dissolution inhibitor |
| 03/25/2009 | EP2039361A2 Use of immunomodulatory compounds |
| 03/25/2009 | EP2038297A1 Porphyromonas gingivalis polypeptides useful in the prevention of periodontal disease |
| 03/25/2009 | EP2037937A2 Tri and tetra-oligo-saccharides suitable as agglutination agents for enteric pathogens |
| 03/25/2009 | EP2000469A9 Acylaminopiperidine compound |
| 03/25/2009 | EP1793859B1 Treatment of oral and intestinal mucositis by administering human il-18 |
| 03/25/2009 | EP1555265B1 7-phenyl pyrazolopyridine compounds |
| 03/25/2009 | EP1299421B1 Antibodies to human mcp-1 |
| 03/25/2009 | EP1287035B1 An antibody selective for a tumor necrosis factor-related apoptosis-inducing ligand receptor and uses thereof |
| 03/25/2009 | CN101395154A 8-azabicyclo[3.2.1]octane compounds as mu opioid receptor antagonists |
| 03/25/2009 | CN101395137A Substituted 2-amino-4-phenyl-dhydroquinolines, method for the production thereof, use thereof as medicaments, and medicaments containing them |
| 03/25/2009 | CN101394859A Extract of herbal and the composition containing the same |
| 03/25/2009 | CN101394751A Animal food composition comprising nut shell |
| 03/25/2009 | CN101392218A Nutrient health wine brewed by natural honey and Chinese herbal medicine and preparation method thereof |
| 03/25/2009 | CN101392015A Triterpene saponin in camellia seeds, preparation method and medical use thereof |
| 03/25/2009 | CN101392001A Carboxamides derivates, preparation method thereof and use on medicine |
| 03/25/2009 | CN101391993A Method for preparing S-omeprazole and salt thereof by forming inclusion complex with (S)-(-)-1,1'-dinaphthalene-2,2'-diol |
| 03/25/2009 | CN101391089A Oral liquid for treating deficient spleen dysfunction and qi stagnation obstruction type gastropathy |
| 03/25/2009 | CN101391088A Enterogastritis oral medicine |
| 03/25/2009 | CN101391079A Traditional Chinese medicine for treating fatty liver |
| 03/25/2009 | CN101391078A Internal medicine for treating fatty liver |
| 03/25/2009 | CN101391075A Mixed traditional Chinese medicine health-care pillow |
| 03/25/2009 | CN101391072A Traditional Chinese medicine for treating diabetic diarrhea |
| 03/25/2009 | CN101391063A Health care medicinal liquor |
| 03/25/2009 | CN101391058A Preparation for clearing away the heat-evil and expelling superficial evils |
| 03/25/2009 | CN101391055A Qi restoring and regulating medicine diet |
| 03/25/2009 | CN101391012A Composite radish seed juice for treating elderly constipation |
| 03/25/2009 | CN101391011A Pure Chinese herbal medicine gargle water for treating oral inflammation |
| 03/25/2009 | CN101391004A Medicine composition for treating late-stage esophageal carcinoma |
| 03/25/2009 | CN101390989A Traditional Chinese medicine preparation for treating recurrent oral ulcer |
| 03/25/2009 | CN101390984A Quality control method of Lanhuayao |
| 03/25/2009 | CN101390970A Traditional Chinese medicine for treating hepatitis B and preparation method thereof |
| 03/25/2009 | CN101390968A Chinese herbal medicine composition for treating intestinal tract disease and preparation method and use thereof |
| 03/25/2009 | CN101390924A Heart-calming kidney-nourishing oral liquid and preparation method thereof |
| 03/25/2009 | CN101390867A Compositions and methods for the treatment of infection |
| 03/25/2009 | CN101390866A Supplies for removing odor |
| 03/25/2009 | CN101390859A Medicine composition containing omeprazole and domperidone |
| 03/25/2009 | CN101390857A Medicine composition containing lansoprazole |
| 03/25/2009 | CN101390851A Double-cyclitol medicine composition containing surfactant and preparation method thereof |
| 03/25/2009 | CN101390850A Hepatinica for tilapia |
| 03/25/2009 | CN100471957C Adenovirus vectors for immunotherapy |
| 03/25/2009 | CN100471869C Preparation and assaying of peptide dextran possessing detectable oral absorption immune regulation of coriolus versicolor |
| 03/25/2009 | CN100471857C Purine derivatives |
| 03/25/2009 | CN100471838C VLA-4 inhibitors |
| 03/25/2009 | CN100471519C Medicinal composition for treating gastropathy and its preparing method and use |
| 03/25/2009 | CN100471518C Chinese medicinal powder with gall, giant knotweed, hyacinth bletilla and bornel |
| 03/25/2009 | CN100471511C Medicinal composition for treating astriction |
| 03/25/2009 | CN100471501C Treatment and prophylaxis of diseases and infections of pigs and poultry |
| 03/25/2009 | CN100471488C Chinese medicine composition for transquilizing, warming Yang, benefiting Qi and nourishing heart and its prepn |
| 03/24/2009 | US7507829 Solid states of pantoprazole sodium, processes for preparing them and processes for preparing known pantoprazole sodium hydrates |
| 03/24/2009 | US7507816 Compounds for treatment of inflammation, antidepressants, nervous system disorders, cardiovascular disorders or analgesics from mannich reaction |
| 03/24/2009 | US7507795 Zcytor17 ligand cytokine; immunostimulators system, and proliferation and/or development of hematopoietic cells in vitro and in vivo; transcription, gene expression, culturing; anticarcinogenic and antiinflammatory agents; diabetes, pancreatitis, inflammatory bowel disease; autoimmune diseases |
| 03/24/2009 | US7507767 Sulfonamide-containing benzene derivatives which exhibit anti-inflammatory and immunodulatory activity |
| 03/24/2009 | US7507762 Substituted 4H-chromene and analogs as activators of caspases and inducers of apoptosis and the use thereof |